is 12.5 mg of tirzepatide a lot Dosing Explanation Troubling Findings in Study of

Jager KJ, et al

Our supplements are intended to be used under the close supervision and direct care of a licensed or certified healing arts professional

J Kohll RX Compounding compounds formulations using semaglutide and tirzepatide, two GLP-1 receptor agonists that may be used when compounded alternatives are indicated

Zepbound: In the 72-week SURMOUNT-1 clinical trial, the following results were observed for different dosages of Zepbound when compared to a placebo: 5 mg/week: 16% weight loss or an average reduction of 35.5 lb (16.1 kg) 10 mg/week: 21.4% weight loss or an average reduction of 48.9 lb (22 kg) 15 mg/week: 22.5% weight loss or an average reduction of 52 lb (23.6 kg) Placebo: 2.4% weight loss or an average reduction of 5.3 lb (2.4 kg) Furthermore, after 72 weeks, between 85% to 91% of those on Zepbound achieved a body weight reduction of 5% or more, compared to only 35% on placebo

It is cardio-safe and well-tolerated